PLK1 and head and neck squamous cell carcinoma: Other kinases that have been evaluated as targets in preclinical or clinical studies in HNSCC include Aurora A (AURKA) [10,11,12] and Polo-like kinase 1 (PLK1) [13], required for entry into and progression through M phase.